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Camryn Bernheimer, Erin Kelly, PhD, Lara Weinstein, MD*
Introduction
• Opioid crisis has devastated Philadelphia on an individual, 
community, and SES level 
• PA exceeds national averages for opioid dependence and 
abuse
– 6th highest drug overdose rate in the nation
• Improved access and quality is needed
• Improvement to logistical, administrative, and stigma related 
barriers
• COVID-19 disrupted the lives of people globally and 




– How has COVID-19 impacted MAT service 
utilization, access to care, and substance use for 
individuals with opioid use disorder (OUD)? 
• Hypothesis
– MAT service use and access to care decreased, 
while substance use increased in patients with 
OUD after COVID-19 when compared to those 
prior to COVID-19. 
Approach & Results
• Study design- medical chart review
– Demographics
– Number of MAT, PCP, and BHC visits
– Urine drug testing 
• MAT patients at Stephen Klein Wellness Center and 
Pathways to Housing PA
– n = 170 
• COVID-19 was defined as 3/14/2020 
– 3 months prior to COVID-19 compared to 3 months post COVID-
19. 
• Analysis 
– Frequencies and Fischer's exact test for demographic analysis
– Independent t-test to compare categorical-continuous 
relationships
– Paired t-test when evaluating pre-post relationships 
Approach & Results
• 91% retention rate 
• 26 new patients Post COVID-19
– No significant difference in demographics or location utilized
• Average number of MAT and BHC visits decreased 
significantly post COVID-19, while PCP visits stayed the 
same
– No significant difference in patients meeting appointment 
guidelines (1 MAT visit per month) 
– Post COVID-19 MAT visits
• Significant difference in Hispanic vs. non-Hispanic patients
• No significant difference
– white vs. non-white patients
– female vs. male
– Location utilized
• Urine drug screening
– Overall decrease in the number of positive and 
negative tests post COVID-19
– Proportion of tests that were positive pre vs. post
• Significant decrease in positive buprenorphine tests
• No significant difference for opioids, cocaine, 
marijuana, or fentanyl positive tests
Conclusions
• Patients are being retained in OUD treatment 
regardless of demographic variables. 
• OUD patients are overall coming in for less 
appointments and less adherent to 
buprenorphine. 
• This could help create new guidelines for how 
best to treat OUD patients during COVID-19. 
Future Directions
• Follow up if there has been changes over time 
• Determine if telemedicine has played a role in 
results 
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